Click on image to view larger version.

Figure 1 Effect of TLV on Time to Death or Heart Failure Hospitalization

Time-to-event analysis evaluating patients randomized to tolvaptan (TLV) (red line) versus placebo (PLC) (blue line) with regard to death or hospitalization for worsening heart failure. There was a favorable effect of TLV on this combined end point.